bibliographicCitation |
Berthold DR, Pond GR, Roessner M, de Wit R, Eisenberger M, Tannock AI; TAX-327 investigators. Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study. Clin Cancer Res. 2008 May 01;14(9):2763–7. doi: 10.1158/1078-0432.ccr-07-0944. PMID: 18451243. |